BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17205694)

  • 1. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors].
    Cavdar E; Kuştimur S; Doğruman Al F
    Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
    Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
    Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
    Mutlu B; Meriç M; Willke A
    Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
    Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
    Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam.
    Bjoerkvoll B; Viet L; Ol HS; Lan NT; Sothy S; Hoel H; Gutteberg T; Husebekk A; Larsen S; Husum H
    Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1127-35. PubMed ID: 21073033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective evaluation of HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody seropositivity in blood donors at the Trabzon Farabi Hospital].
    Aydin F; Cubukçu K; Yetişkul S; Yazici Y; Kaklikkaya N
    Mikrobiyol Bul; 2002 Jan; 36(1):85-90. PubMed ID: 12476771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan.
    Kakepoto GN; Bhally HS; Khaliq G; Kayani N; Burney IA; Siddiqui T; Khurshid M
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):703-6. PubMed ID: 9253870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short communication: hepatitis B, hepatitis C and human immunodeficiency virus seropositivities in women admitted to Sanliurfa Gynecology and Obstetrics Hospital].
    Tekay F; Ozbek E
    Mikrobiyol Bul; 2006 Oct; 40(4):369-73. PubMed ID: 17205695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt.
    El-Gilany AH; El-Fedawy S
    East Mediterr Health J; 2006 Nov; 12(6):742-8. PubMed ID: 17333818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia.
    Ol HS; Bjoerkvoll B; Sothy S; Van Heng Y; Hoel H; Husebekk A; Gutteberg T; Larsen S; Husum H
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):963-71. PubMed ID: 19842380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBsAg, anti-HCV, anti-HIV 1/2 and syphilis seroprevalence in healthy volunteer blood donors in southeastern Anatolia.
    Dayan S; Tekin A; Tekin R; Dal T; Hoşoğlu S; Yazgan UC; Bekçibaşı M; Gül K
    J Infect Dev Ctries; 2013 Sep; 7(9):665-9. PubMed ID: 24042102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma donor screening and product safety].
    Storch H; Ponsel G; Igel H; Worofka R
    Beitr Infusionsther Transfusionsmed; 1997; 34():31-6. PubMed ID: 9417350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
    Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
    J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the testing of non-heart-beating cadavers for viral markers: implications for the safety of tissue donors.
    Padley D; Ferguson M; Warwick RM; Womack C; Lucas SB; Saldanha J
    Cell Tissue Bank; 2005; 6(3):171-9. PubMed ID: 16151957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBsAg, anti-HCV and anti-HIV seroprevalence among blood donors in Southeastern Anatolia, Turkey, 2011-2015.
    Dayan S; Özekinci T; Bekçibaşi M; Deveci Ö
    Infez Med; 2019 Sep; 27(3):316-321. PubMed ID: 31545776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P; Pickard G; Gammie A; Atkins M
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for markers of transfusion-associated infections in autologous blood donation].
    Zimmermann R; Schwella N; Weissbach V; Heuft HG; Eckstein R
    Beitr Infusionsther Transfusionsmed; 1994; 32():488-91. PubMed ID: 9480148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
    Wiedmann M; Kluwick S; Walter M; Fauchald G; Howe J; Bronold M; Zauke M
    J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.